Inteliswab
Payments companies reported to CMS as associated with Inteliswab. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Inteliswab, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Inteliswab
These are the largest totals companies reported as associated with Inteliswab. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Nancy Gagliano | Boston, MA | Internal Medicine | $188,895.73 |
| David Shulkin | Morristown, NJ | Internal Medicine | $169,720.55 |
| Paul Drain | Seattle, WA | Infectious Disease | $22,529.42 |
| Karl Gallegos | Kennesaw, GA | $12,587.50 | |
| Leandro Mena | Atlanta, GA | Infectious Disease | $1,000.00 |
| Fares Khater | Whitesburg, KY | Internal Medicine | $1,000.00 |
| Jonathan Zenilman | Baltimore, MD | Infectious Disease | $26.71 |
| Kelly Cowen | Rockville, MD | Family Medicine | $26.11 |
| Alicia Post | Rockville, MD | Family | $26.10 |
| Ira Berger | Rockville, MD | Internal Medicine | $26.10 |
Prescribed Inteliswab?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.